Peter Zimetbaum, MD1: From the 1Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA

home / authors / peter-zimetbaum-md1-from-the-1division-of-cardiology-beth-israel-deaconess-medical-center-boston-ma

Articles

Amiodarone use and permanent pacing for atrial fibrillation: Are there differences between the sexes?

Matthew R. Reynolds, MD, MSc1;Vidal Essebag, MD, PhD2;Ethan J. Ellis, MD1;Peter Zimetbaum, MD1: From the 1Division of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA;the 2Divisio

July 23rd 2008

Among patients with atrial fibrillation, amiodarone (Cordarone, Pacerone) is the most useful drug for the preservation of sinus rhythm.1-3 Although amiodarone carries a well-known risk of potentially serious noncardiac toxicities, perhaps less well recognized is its major cardiovascular side effect of bradycardia.